abstract |
The present invention relates to novel compounds of formula (I) capable of inhibiting the activity of the FabI enzyme, which are useful for the treatment of bacterial infections. Furthermore, the present invention relates to pharmaceutical compositions comprising these compounds and to chemical processes for preparing these compounds. |